← SynDRA
EPZ-005687
SynDRA canonical compound SYN0050978 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EZH2 |
|---|
| Mechanism of action | histone lysine methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EZH2 INHIBITOR
- histone lysine methyltransferase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- EPZ005687
- EPZ 005687
- Epz005687
- RefChem:921078
- EZH2 Inhibitor, EPZ005687
- MFCD25372029
- GQ4LD5KG1E
- EPZ 5687 [WHO-DD]
- EPZ-5687
- C32H37N5O3
- ZOIBZSZLMJDVDQ-UHFFFAOYSA-N
- UNII-GQ4LD5KG1E
- GTPL8387
- orb1307167
- SCHEMBL12684069
- SCHEMBL29357504
- EX-A429
- CHEBI:124922
- NSC783332
- s7004
- AKOS026750254
- CCG-269957
- CS-1215
- EBC-414041
- EPZ005687?
- NSC-783332
- SB19050
- NCGC00351604-01
- NCGC00351604-09
- NCGC00351604-11
- NCGC00351604-12
- AC-32708
- AS-16367
- DA-34778
- HY-15555
- E6396
- F863278
- BRD-K57754230-001-02-7
- 1-Cyclopentyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide
Look up EPZ-005687 in the interactive SynDRA portal →